#news #biotech AstraZeneca drops Dupixent rival tezepelumab in atopic dermatitis as asthma focus sharpens

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca drops Dupixent rival tezepelumab in atopic dermatitis as asthma focus sharpens .AstraZeneca drops Dupixent rival tezepelumab in atopic dermatitis as asthma focus sharpens
ntaylor
Thu, 07/29/2021 – 06:21

from FierceBiotech: Biotech https://ift.tt/376hLXp